tiprankstipranks
Galera Therapeutics (GRTX)
OTHER OTC:GRTX
US Market
GRTX
Galera Therapeutics
RESEARCH TOOLSreports
Want to see GRTX full AI Analyst Report?

Galera Therapeutics (GRTX) Income Statement

260 Followers

Galera Therapeutics Income Statement

Last quarter (Q4 2025), Galera Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Galera Therapeutics's net income was $153.10M. See Galera Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.84M$ -259.00K$ -114.00K$ -778.00K
Operating Expenses
$ 6.04M$ 14.15M$ 46.69M$ 51.23M$ 73.37M
Depreciation and Amortization
$ 0.00$ 20.00K$ 259.00K$ 114.00K$ 778.00K
EBITDA
$ -6.04M$ -20.16M$ -70.24M$ -50.61M$ -72.56M
Operating Income
$ -6.04M$ -20.16M$ -46.95M$ -51.23M$ -73.37M
Other Income/Expenses
$ 155.09M$ 1.00M$ -12.13M$ -11.07M$ -7.17M
Pretax Income
$ 149.05M$ -19.16M$ -59.08M$ -62.29M$ -80.53M
Net Income
$ 149.05M$ -18.96M$ -59.08M$ -62.22M$ -80.53M
Per Share Metrics
Basic EPS
$ 1.51$ -0.35$ -1.33$ -2.30$ -3.40
Diluted EPS
$ 1.51$ -0.35$ -1.33$ -2.30$ -3.40
Weighted Average Shares Outstanding
 98.50M 54.63M 44.55M 27.09M 25.79M
Weighted Average Shares Outstanding (Diluted)
 98.50M 54.63M 44.55M 27.09M 25.79M
Currency in USD

Galera Therapeutics Earnings and Revenue History